| Returns | 1W : -4.6% , 1M : -5.2%,1Y : 37.4% |
| LT : |
Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : High |
| ST : |
Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
| Peers & Returns | 1W | 1M | 1Y |
| NARAYANA HRUDAYALAYA | -4.6% | -5.2% | 37.4% |
| APOLLO HOSPITALS ENTERPRISE | 9.9% | 9.2% | 129.5% |
| DR LAL PATHLABS | -1.6% | 18.4% | 97.3% |
| FORTIS HEALTHCARE | 3.6% | 12.7% | 69.3% |
| METROPOLIS HEALTHCARE | 2.3% | 30.7% | 98.7% |
| ASTER DM HEALTHCARE | 3.6% | 6.8% | 40.3% |
| THYROCARE TECHNOLOGIES | 0.4% | 17.9% | 93.8% |
| SHALBY | 9.4% | 19.8% | 63.6% |
| KOVAI MEDICAL CENTER & HOSPITAL | 5.3% | 10.7% | 73.4% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
68.78
P/E Calculated based on EPS of 5.82
[ Mar2020 - Consolidated Results ] 7.22
P/B Calculated based on Book Value of 55.42
[ Mar2020 - Consolidated Results ] 2.98
P/S Calculated based on Revenues of 2743.94 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
-12% 0% 19% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 4.4% | 13% | 55.2% |
| S&P BSE SMALL CAP | -0.1% | 0.3% | 91.4% |
| S&P BSE MIDSMALLCAP | -0.3% | -0.3% | 79.7% |
| S&P BSE 400 MIDSMALLCAP | -0.4% | -0.8% | 81% |
| S&P BSE 250 SMALLCAP | -1% | -2.2% | 88.2% |
| S&P BSE ALLCAP | -1.1% | -2.1% | 60% |
| S&P BSE 500 | -1.1% | -2.2% | 59.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MID SMALL400 | -0.7% | -1% | 81% |
| NIFTY SMALLCAP250 | -0.7% | -1.2% | 90.7% |
| NIFTY 500 | -1.1% | -2.2% | 58.6% |
